Does Medicare Cover Weight Loss Drugs?

Medicare.gov says Medicare will provide access to certain GLP-1 drugs if you’re eligible and have Medicare drug coverage (Part D). This is the temporary Medicare GLP-1 Bridge program: CMS describes it as a short-term demonstration between July 1, 2026, and December 31, 2027. If you qualify, you pay a $50 copayment for a one-month supply. You must be 18 or older and meet one of the BMI and health-condition requirements quoted below, and CMS says eligible GLP-1s are only furnished under the Bridge, with the $50 co-pay, when prescribed for a weight management indication. CMS also says a beneficiary who has previously filled a GLP-1 prescription through their Part D plan in 2026 is not eligible for coverage through the Bridge in 2026. For Part B, medicare.gov says Part B covers obesity screenings and behavioral counseling, if you’re eligible.

Maintained by Archie Chang · Reviewed November 14, 2026 · Methodology & sources

Not an official source. FedRateCalc is independent and is not affiliated with Medicare, the Centers for Medicare & Medicaid Services (CMS) or any government agency. Medicare.gov is the authority on what Medicare covers and what it costs. This page quotes medicare.gov and CMS publications as saved on the dates listed under Sources, and reports what they say.

The Medicare GLP-1 Bridge

Medicare.gov’s weight loss drugs page says:

“Medicare will provide access to certain GLP-1 drugs if you’re eligible and have Medicare drug coverage (Part D)”
Medicare.gov: Weight loss drugs
“GLP-1 drugs can help you manage your weight and improve your health. Starting July 1, 2026, Medicare covers these GLP-1 drugs:
Foundayo® (tablet)

Wegovy® (injection or tablet)

Zepbound® (KwikPen® only. The program doesn’t cover single-dose Zepbound® vials or pens).
”
Medicare.gov: Weight loss drugs
“Medicare covers certain GLP-1 drugs under the Medicare GLP-1 Bridge program. This temporary program is available nationwide (including all states and U.S. territories) to certain people with Medicare drug coverage (Part D), including:
A standalone Medicare drug plan (PDP)

A Medicare Advantage (MA) coordinated care plan with drug coverage (including HMO, HMOPOS, and Local and Regional PPO plans) (MA-PD)

A Special Needs Plan (SNP)

An Employer/union group waiver plan (EGWP)

The Limited Income Newly Eligible Transition (LI NET) program
”
Medicare.gov: Weight loss drugs

When it runs

CMS says:

“The Medicare GLP-1 Bridge is a short-term demonstration run by CMS that will provide eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs between July 1, 2026, and December 31, 2027.”
CMS: Medicare GLP-1 Bridge
“The Medicare GLP-1 Bridge will be extended through December 31, 2027, providing eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs and allowing CMS to collect additional data on GLP-1 utilization to share with Part D plan sponsors ahead of potential implementation of BALANCE in Part D.”
CMS: Medicare GLP-1 Bridge

Medicare.gov adds on the prior authorization:

“Your prior authorization is valid (including for refills and dose changes) through December 31, 2027, unless you change GLP-1s.”
Medicare.gov: Weight loss drugs

Who is eligible

“You must be 18 or older and meet one of these requirements when you start GLP-1 therapy:
You have a body mass index (BMI) of 35 or higher.

You have a BMI of 30 or higher and you have at least one of these conditions:

Diastolic heart failure (also called heart failure with preserved ejection fraction)

Uncontrolled high blood pressure (also called hypertension)

Chronic kidney disease at stage 3a or higher

You have a BMI of 27 or higher and have at least one of these conditions:

Prediabetes

A previous heart attack (also called myocardial infarction) or stroke

Blocked arteries in your legs or arms (also called peripheral artery disease) with symptoms
”
Medicare.gov: Weight loss drugs

CMS defines the uncontrolled high blood pressure condition this way:

“The beneficiary is at least eighteen (18) years of age and has a BMI greater than or equal to thirty (≥30) at the time of initiating GLP-1 therapy with a diagnosis of one or more of the following: (A) heart failure with preserved ejection fraction, (B) uncontrolled hypertension (defined as systolic blood pressure above 140 mm Hg or diastolic blood pressure above 90 mm Hg, despite concurrent treatment with two antihypertensive medications), or (C) chronic kidney disease stage 3a or above”
CMS: Medicare GLP-1 Bridge, information for Part D plans
“You aren't eligible if you:
Already get GLP-1 drugs covered through your Medicare Part D plan.

Have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease (but your Part D plan might cover your GLP-1s).
”
Medicare.gov: Weight loss drugs

CMS says on people who already received a GLP-1 through Part D:

“If the beneficiary has previously filled a prescription for a GLP-1 through their Part D plan in 2026, they are not eligible for coverage through Medicare GLP-1 Bridge in 2026, even if that coverage was supplemental coverage of weight management by their Part D plan. Such a beneficiary should continue to seek treatment through their Part D plan.”
CMS: Medicare GLP-1 Bridge, information for Part D plans
“If you’re eligible, your doctor or other health care provider must send a prescription for a covered GLP-1 drug to the pharmacy and when requested, complete a prior authorization. Your provider must certify that you're using the GLP-1 drug as part of a lifestyle program that focuses on diet and exercise.”
Medicare.gov: Weight loss drugs

What it costs

Medicare.gov says:

“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).
Since a separate Medicare program covers this drug (not your regular drug coverage), your copayment:

Doesn’t count towards your yearly Medicare drug plan deductible or out-of-pocket limit and won’t appear on your Part D Explanation of Benefits (EOB).

Won’t appear on any Medicare Summary Notice (MSN).

Can’t be lowered by programs like Extra Help (a Medicare program that helps people with limited income and resources pay Part D costs).

Can’t be spread across multiple months using the Medicare Prescription Payment Plan.
”
Medicare.gov: Weight loss drugs

CMS says on how the Bridge relates to Part D:

“Eligible beneficiaries will have a $50 copay. Eligible GLP-1 drugs furnished under the Medicare GLP-1 Bridge are provided outside of the Part D benefit payment flow and coverage. This means that the Part D deductible will not apply, no part of the $50 copay counts towards the beneficiary’s TrOOP costs, and there is no low-income subsidy (LIS) provided for LIS beneficiaries.”
CMS: Medicare GLP-1 Bridge
“The Medicare GLP-1 Bridge was designed to increase access to GLP-1s for beneficiaries who seek the drug solely to reduce excess body weight or maintain weight reduction. Type 2 diabetes, moderate to severe obstructive sleep apnea, and noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis) indications are eligible for Part D coverage. Beneficiaries with these diagnoses are eligible to receive GLP-1s through their Part D plan and therefore are ineligible to receive them through the Medicare GLP-1 Bridge, even if they otherwise meet the Medicare GLP-1 Bridge clinical criteria. Eligible GLP-1s are only furnished under the Medicare GLP-1 Bridge, with the $50 co-pay, when prescribed for a weight management indication. If a Medicare Part D beneficiary has a prescription for a GLP-1 drug for an indication covered under Medicare Part D, they should continue to obtain their GLP-1 through their Part D plan.”
CMS: Medicare GLP-1 Bridge, information for Part D plans

Part B: obesity screening and behavioral counseling

“Medicare Part B (Medical Insurance) covers obesity screenings and behavioral counseling, if you're eligible”
Medicare.gov: Obesity behavioral therapy
“Obesity behavioral therapy includes an initial screening for BMI, and behavioral therapy sessions that include a dietary assessment and counseling to help you lose weight by focusing on diet and exercise.”
Medicare.gov: Obesity behavioral therapy
“Part B covers obesity screenings and behavioral counseling. You must get the counseling from your primary care doctor or other primary care provider in a primary care setting (like a doctor's office), where they can coordinate your personalized prevention plan with your other care.”
Medicare.gov: Obesity behavioral therapy
“You must meet certain weight loss requirements for Medicare to continue to cover this counseling.”
Medicare.gov: Obesity behavioral therapy
“You must have a body mass index (BMI) of 30 or more.”
Medicare.gov: Obesity behavioral therapy
“You pay nothing for this service if your primary provider accepts assignment.”
Medicare.gov: Obesity behavioral therapy

Frequently asked questions

Does Medicare cover weight loss drugs?

Medicare.gov says: “Medicare will provide access to certain GLP-1 drugs if you’re eligible and have Medicare drug coverage (Part D).” It also says: “Medicare covers certain GLP-1 drugs under the Medicare GLP-1 Bridge program.”

Who is eligible for the Medicare GLP-1 Bridge?

Medicare.gov says: “You must be 18 or older and meet one of these requirements when you start GLP-1 therapy: You have a body mass index (BMI) of 35 or higher. You have a BMI of 30 or higher and you have at least one of these conditions: Diastolic heart failure (also called heart failure with preserved ejection fraction) Uncontrolled high blood pressure (also called hypertension) Chronic kidney disease at stage 3a or higher You have a BMI of 27 or higher and have at least one of these conditions: Prediabetes A previous heart attack (also called myocardial infarction) or stroke Blocked arteries in your legs or arms (also called peripheral artery disease) with symptoms” “You aren't eligible if you: Already get GLP-1 drugs covered through your Medicare Part D plan. Have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease (but your Part D plan might cover your GLP-1s).”

What is the copayment for GLP-1 drugs under Medicare?

Medicare.gov says: “You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).” CMS says: “Eligible beneficiaries will have a $50 copay.”

How long does the Medicare GLP-1 Bridge last?

CMS says: “The Medicare GLP-1 Bridge is a short-term demonstration run by CMS that will provide eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs between July 1, 2026, and December 31, 2027.” “The Medicare GLP-1 Bridge will be extended through December 31, 2027, providing eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs and allowing CMS to collect additional data on GLP-1 utilization to share with Part D plan sponsors ahead of potential implementation of BALANCE in Part D.”

Does Medicare Part B cover obesity counseling?

Medicare.gov says: “Medicare Part B (Medical Insurance) covers obesity screenings and behavioral counseling, if you're eligible.” “You must have a body mass index (BMI) of 30 or more.”

Can people with diabetes get weight loss drugs through Medicare?

Medicare.gov says: “You aren't eligible if you: Already get GLP-1 drugs covered through your Medicare Part D plan. Have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease (but your Part D plan might cover your GLP-1s).” CMS says: “The Medicare GLP-1 Bridge was designed to increase access to GLP-1s for beneficiaries who seek the drug solely to reduce excess body weight or maintain weight reduction. Type 2 diabetes, moderate to severe obstructive sleep apnea, and noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis) indications are eligible for Part D coverage. Beneficiaries with these diagnoses are eligible to receive GLP-1s through their Part D plan and therefore are ineligible to receive them through the Medicare GLP-1 Bridge, even if they otherwise meet the Medicare GLP-1 Bridge clinical criteria. Eligible GLP-1s are only furnished under the Medicare GLP-1 Bridge, with the $50 co-pay, when prescribed for a weight management indication. If a Medicare Part D beneficiary has a prescription for a GLP-1 drug for an indication covered under Medicare Part D, they should continue to obtain their GLP-1 through their Part D plan.”

Sources

Quotes are verbatim; “[…]” marks every omission. Each source shows the date it was retrieved.